HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HANXBIO-B

31.160

+0.9603.18%

Volume:33.90K

Turnover:1.04M

Market Cap:4.18B

PE:-28.07

High:31.500

Open:30.500

Low:29.500

Close:30.200

52wk High:33.800

52wk Low:13.480

Shares:134.00M

HK Float Shares:134.00M

Volume Ratio:1.55

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.110

ROE:-27.27%

ROA:-12.63%

PB:5.13

PE(LYR):-28.07

PS:38894.25

Loading ...

Overview Company News Filings

HANXBIO-B Buys Back 22,600 H Shares at Average HK$32.09; Treasury Stock Reaches 547,300 Shares

Bulletin Express

HANXBIO-B (03378) Spends HK$725,000 on Share Buyback of 22,600 Shares on May 11

Hanx Biopharmaceuticals files HKEX next-day return, discloses buyback at HKD 32.09/share

HANXBIO-B (03378) Allocates HK$704,500 for Share Buyback on May 8

Hanx Biopharmaceuticals files HKEX disclosure return, repurchases shares at HKD 32.02 each

HANXBIO-B repurchases 16,600 H-shares for HK$0.52 million, treasury stock rises to 502,700 units

Bulletin Express

HANXBIO-B (03378) Spends HK$795,700 on Share Buyback of 25,900 Shares on May 6

Hanx Biopharmaceuticals buys back 32,700 H shares for HKD 0.97 million; treasury stock rises to 446,100 shares

Bulletin Express

HANXBIO-B (03378) Spends HK$972,000 on Share Buyback of 32,700 Shares on April 29

Hanx Biopharmaceuticals files HKEX disclosure, repurchases shares at HKD 29.74 each

HANXBIO-B Repurchases Shares Worth HK$1.02 Million on April 28

HANXBIO-B (03378) Allocates HK$1.06 Million for Share Buyback on April 27

Hanx Biopharma files HKEX next-day return, discloses HKD 27.85 share buyback

HANXBIO-B（03378）2025年经营表现与结构升级：研发投入加码，资产大幅提升

Bulletin Express

Hanx Biopharmaceuticals releases 2025 ESG report

Hanx Biopharmaceuticals publishes 2025 annual report

HANXBIO Executes HKD 1.06 Million Share Buyback, Lifts Treasury Stock to 0.25% of Mandated Limit

Bulletin Express

HANXBIO-B (03378) Unveils Four Key Preclinical Research Findings at 2026 AACR Annual Meeting

Hanx Biopharmaceuticals says HX044 enters Phase I after positive preclinical data at AACR

HANXBIO-B spends HKD 0.99 million to repurchase 31,200 H shares; outstanding shares (ex-treasury) trimmed to 135.94 million

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/03378/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"03378","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03378\",,,,,undefined,":{"symbol":"03378","market":"HK","secType":"STK","nameCN":"HANXBIO-B","latestPrice":31.16,"timestamp":1787299687090,"preClose":30.2,"halted":0,"volume":33900,"delay":0,"changeRate":0.0317880794701987,"floatShares":134000000,"shares":134000000,"eps":-1.11,"marketStatus":"Market Closed","change":0.96,"latestTime":"08-21 16:08:07","open":30.5,"high":31.5,"low":29.5,"amount":1036316,"amplitude":0.066225,"askPrice":31.16,"askSize":800,"bidPrice":30.54,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-1.129,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1766419200000,"exchange":"SEHK","adjPreClose":30.2,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":1.5451230741668045,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"000905","market":"SZ","secType":"STK","nameCN":"Xiamen Port Development Co.,Ltd.","latestPrice":8.57,"timestamp":1787295600000,"preClose":8.51,"halted":0,"volume":6043500,"delay":0,"premium":"+211.59"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03378\",,,,,undefined,":{"symbol":"03378","floatShares":134000000,"roa":"-12.63%","roe":"-27.27%","lyrEps":-1.11,"volumeRatio":1.5451230741668045,"shares":134000000,"dividePrice":0,"high":31.5,"amplitude":0.066225,"preClose":30.2,"low":29.5,"week52Low":13.48,"pbRate":"5.13","psRate":"38894.25","week52High":33.8,"institutionHeld":0,"latestPrice":31.16,"committee":-0.777778,"eps":-1.11,"divideRate":0,"volume":33900,"delay":0,"ttmEps":-1.129,"open":30.5,"prevYearClose":15.98,"prevWeekClose":30.38,"prevMonthClose":28.56,"prevQuarterClose":28.6,"fiveDayClose":30.38,"twentyDayClose":26.9,"sixtyDayClose":27.72},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03378\",params:#limit:5,,,undefined,":[{"date":"2026-08-17","symbol":"03378","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786930200000,"name":null,"time":"","dateTimestamp":1786896000000,"actualEps":null},{"date":"2026-03-27","symbol":"03378","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774575000000,"name":null,"time":"","dateTimestamp":1774540800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03378\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03378\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03378\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03378","date":"2026-08-21","current":-27.599646,"percent":0.075949,"low":-33.201019,"twenty":-24.640614,"median":4.815493,"eighty":5.392136,"high":11.144666,"avg":-5.757209,"sd":15.087554,"marketCap":4244578742},"quantilePoints":[{"date":"2021-08-27","current":6.211114,"twenty":6.21107,"median":8.882761,"eighty":10.607478,"marketCap":2453580000},{"date":"2021-09-03","current":5.545615,"twenty":6.208353,"median":8.884377,"eighty":10.608943,"marketCap":2453580000},{"date":"2021-09-10","current":5.900149,"twenty":6.193519,"median":8.880182,"eighty":10.608943,"marketCap":2617152000},{"date":"2021-09-17","current":5.547797,"twenty":6.178602,"median":8.879984,"eighty":10.608211,"marketCap":2453580000},{"date":"2021-09-24","current":5.395896,"twenty":6.168457,"median":8.870647,"eighty":10.603497,"marketCap":2371794000},{"date":"2021-09-30","current":5.316083,"twenty":6.15787,"median":8.864959,"eighty":10.580915,"marketCap":2344532000},{"date":"2021-10-08","current":5.316326,"twenty":6.147257,"median":8.853246,"eighty":10.544157,"marketCap":2344532000},{"date":"2021-10-15","current":5.374457,"twenty":6.140429,"median":8.815924,"eighty":10.511884,"marketCap":2371794000},{"date":"2021-10-22","current":5.27481,"twenty":6.127225,"median":8.797247,"eighty":10.493516,"marketCap":2344532000},{"date":"2021-10-29","current":5.349373,"twenty":6.119344,"median":8.779365,"eighty":10.475509,"marketCap":2371794000},{"date":"2021-11-05","current":4.889355,"twenty":6.114079,"median":8.748721,"eighty":10.420921,"marketCap":2208222000},{"date":"2021-11-12","current":4.809165,"twenty":6.108215,"median":8.717377,"eighty":10.3914,"marketCap":2180960000},{"date":"2021-11-19","current":4.876179,"twenty":6.101111,"median":8.695621,"eighty":10.35108,"marketCap":2208222000},{"date":"2021-11-26","current":4.87462,"twenty":6.084623,"median":8.671197,"eighty":10.318496,"marketCap":2208222000},{"date":"2021-12-03","current":5.22604,"twenty":6.078106,"median":8.624866,"eighty":10.2832,"marketCap":2371794000},{"date":"2021-12-10","current":5.037231,"twenty":6.070936,"median":8.60024,"eighty":10.227378,"marketCap":2290008000},{"date":"2021-12-17","current":4.86069,"twenty":6.054857,"median":8.564239,"eighty":10.190552,"marketCap":2208222000},{"date":"2021-12-24","current":4.916003,"twenty":6.052379,"median":8.514295,"eighty":10.154612,"marketCap":2235484000},{"date":"2021-12-31","current":5.144618,"twenty":6.047568,"median":8.504328,"eighty":10.145926,"marketCap":2344532000},{"date":"2022-01-07","current":5.164225,"twenty":6.042847,"median":8.4784,"eighty":10.143723,"marketCap":2344532000},{"date":"2022-01-14","current":5.093083,"twenty":6.038396,"median":8.458041,"eighty":10.124223,"marketCap":2317270000},{"date":"2022-01-21","current":5.380359,"twenty":6.023881,"median":8.434699,"eighty":10.073347,"marketCap":2453580000},{"date":"2022-01-28","current":5.034519,"twenty":6.017531,"median":8.407204,"eighty":10.033216,"marketCap":2290008000},{"date":"2022-02-04","current":5.156916,"twenty":6.014762,"median":8.39643,"eighty":10.012135,"marketCap":2344532000},{"date":"2022-02-11","current":5.206364,"twenty":6.007032,"median":8.358349,"eighty":9.99186,"marketCap":2371794000},{"date":"2022-02-18","current":5.240469,"twenty":5.997462,"median":8.310368,"eighty":9.985006,"marketCap":2399056000},{"date":"2022-02-25","current":4.989965,"twenty":5.989585,"median":8.200753,"eighty":9.95781,"marketCap":2290008000},{"date":"2022-03-04","current":4.928672,"twenty":5.979555,"median":8.170117,"eighty":9.938791,"marketCap":2262746000},{"date":"2022-03-11","current":4.876653,"twenty":5.973297,"median":8.123652,"eighty":9.894296,"marketCap":2235484000},{"date":"2022-03-18","current":4.717047,"twenty":5.960037,"median":8.070293,"eighty":9.868408,"marketCap":2153698000},{"date":"2022-03-25","current":5.194505,"twenty":5.957174,"median":8.005027,"eighty":9.829511,"marketCap":2371794000},{"date":"2022-04-01","current":4.531371,"twenty":5.948529,"median":7.973288,"eighty":9.81982,"marketCap":2317270000},{"date":"2022-04-08","current":4.649157,"twenty":5.946479,"median":7.953215,"eighty":9.804315,"marketCap":2371794000},{"date":"2022-04-14","current":4.707815,"twenty":5.940486,"median":7.879016,"eighty":9.79455,"marketCap":2399056000},{"date":"2022-04-22","current":4.802247,"twenty":5.934888,"median":7.843904,"eighty":9.78108,"marketCap":2399056000},{"date":"2022-04-29","current":4.825339,"twenty":5.919008,"median":7.698315,"eighty":9.768722,"marketCap":2371794000},{"date":"2022-05-06","current":4.410489,"twenty":5.9041,"median":7.676819,"eighty":9.755607,"marketCap":2399056000},{"date":"2022-05-13","current":4.541874,"twenty":5.900202,"median":7.615768,"eighty":9.747897,"marketCap":2426318000},{"date":"2022-05-20","current":6.290771,"twenty":5.897549,"median":7.514446,"eighty":9.724288,"marketCap":3407750000},{"date":"2022-05-27","current":7.303631,"twenty":5.895161,"median":7.434402,"eighty":9.709875,"marketCap":3952990000},{"date":"2022-06-02","current":7.264641,"twenty":5.89518,"median":7.334535,"eighty":9.703749,"marketCap":3952990000},{"date":"2022-06-10","current":10.869875,"twenty":5.895161,"median":7.322855,"eighty":9.700394,"marketCap":5888592000},{"date":"2022-06-17","current":10.755528,"twenty":5.895161,"median":7.322855,"eighty":9.700394,"marketCap":5806806000},{"date":"2022-06-24","current":10.662581,"twenty":5.895161,"median":7.322855,"eighty":9.700394,"marketCap":5779544000},{"date":"2022-06-30","current":10.731352,"twenty":5.895161,"median":7.322855,"eighty":9.700394,"marketCap":5806806000},{"date":"2022-07-08","current":10.820976,"twenty":5.895141,"median":7.321962,"eighty":9.698882,"marketCap":5861330000},{"date":"2022-07-15","current":10.871399,"twenty":5.895141,"median":7.321962,"eighty":9.698882,"marketCap":5834068000},{"date":"2022-07-22","current":10.864271,"twenty":5.895141,"median":7.321962,"eighty":9.698882,"marketCap":5834068000},{"date":"2022-07-29","current":11.058353,"twenty":5.895141,"median":7.321962,"eighty":9.698882,"marketCap":5943116000},{"date":"2022-08-05","current":11.082085,"twenty":5.895141,"median":7.321962,"eighty":9.698882,"marketCap":5943116000},{"date":"2022-08-29","current":10.115403,"twenty":5.888507,"median":7.263276,"eighty":9.659414,"marketCap":6079426000},{"date":"2022-09-23","current":10.460916,"twenty":5.875785,"median":7.121577,"eighty":9.631568,"marketCap":6106688000},{"date":"2022-09-27","current":10.715865,"twenty":5.875785,"median":7.121577,"eighty":9.635273,"marketCap":6106688000},{"date":"2025-12-24","current":-18.447668,"twenty":4.982674,"median":6.211114,"eighty":10.220738,"marketCap":2368845453},{"date":"2026-01-02","current":-18.02665,"twenty":4.940407,"median":6.084014,"eighty":10.228734,"marketCap":2323893239},{"date":"2026-01-09","current":-17.992416,"twenty":4.931186,"median":6.014515,"eighty":10.205703,"marketCap":2325255428},{"date":"2026-01-16","current":-17.923631,"twenty":4.916421,"median":5.897664,"eighty":10.160138,"marketCap":2323893239},{"date":"2026-01-23","current":-17.982908,"twenty":4.885478,"median":5.797377,"eighty":10.160138,"marketCap":2329341993},{"date":"2026-01-30","current":-17.744046,"twenty":4.875244,"median":5.725499,"eighty":10.160138,"marketCap":2308909168},{"date":"2026-02-06","current":-16.811585,"twenty":4.866613,"median":5.578062,"eighty":10.122459,"marketCap":2193123163},{"date":"2026-02-13","current":-19.892571,"twenty":4.857721,"median":5.514388,"eighty":9.398557,"marketCap":2609952782},{"date":"2026-02-20","current":-19.63014,"twenty":4.838987,"median":5.394615,"eighty":9.188636,"marketCap":2571811510},{"date":"2026-02-27","current":-18.008211,"twenty":4.809165,"median":5.349373,"eighty":9.115992,"marketCap":2385191713},{"date":"2026-03-06","current":-19.720151,"twenty":4.794539,"median":5.318493,"eighty":9.039595,"marketCap":2590882146},{"date":"2026-03-13","current":-19.154995,"twenty":4.734025,"median":5.280689,"eighty":8.898598,"marketCap":2528221484},{"date":"2026-03-20","current":-24.324826,"twenty":4.717047,"median":5.27512,"eighty":8.792193,"marketCap":3198418128},{"date":"2026-03-27","current":-29.829257,"twenty":4.666438,"median":5.249923,"eighty":8.559172,"marketCap":3912204797},{"date":"2026-04-02","current":-33.201019,"twenty":4.649572,"median":5.228098,"eighty":8.438047,"marketCap":4375348819},{"date":"2026-04-10","current":-30.874905,"twenty":4.56464,"median":5.211517,"eighty":8.156734,"marketCap":4100186783},{"date":"2026-04-17","current":-28.990908,"twenty":4.497397,"median":5.194059,"eighty":7.9968,"marketCap":4356278183},{"date":"2026-04-24","current":-26.124785,"twenty":-15.418367,"median":5.160571,"eighty":7.807328,"marketCap":3925826680},{"date":"2026-04-30","current":-28.728082,"twenty":-16.801754,"median":5.147581,"eighty":7.337697,"marketCap":4318136911},{"date":"2026-05-08","current":-29.080272,"twenty":-17.535098,"median":5.128333,"eighty":7.264368,"marketCap":4386246326},{"date":"2026-05-15","current":-25.905424,"twenty":-17.807067,"median":5.103123,"eighty":7.202337,"marketCap":3917653550},{"date":"2026-05-22","current":-25.748089,"twenty":-17.879019,"median":5.092409,"eighty":6.915003,"marketCap":3884961031},{"date":"2026-05-29","current":-25.712847,"twenty":-17.93488,"median":5.048821,"eighty":6.718284,"marketCap":3893134161},{"date":"2026-06-05","current":-24.938916,"twenty":-18.015587,"median":5.038323,"eighty":6.588315,"marketCap":3781434720},{"date":"2026-06-12","current":-24.14671,"twenty":-18.118353,"median":5.023214,"eighty":6.365684,"marketCap":3658837773},{"date":"2026-06-18","current":-24.124788,"twenty":-18.283036,"median":4.995209,"eighty":6.290771,"marketCap":3664286527},{"date":"2026-06-26","current":-23.468119,"twenty":-18.694621,"median":4.985606,"eighty":6.218847,"marketCap":3547138333},{"date":"2026-07-03","current":-26.026177,"twenty":-19.36707,"median":4.949882,"eighty":6.211114,"marketCap":3936724187},{"date":"2026-07-10","current":-26.148322,"twenty":-19.720151,"median":4.931815,"eighty":6.084012,"marketCap":3950346070},{"date":"2026-07-17","current":-25.750118,"twenty":-23.468119,"median":4.916526,"eighty":5.905983,"marketCap":3904031667},{"date":"2026-07-24","current":-24.163383,"twenty":-23.965295,"median":4.886124,"eighty":5.872595,"marketCap":3664286527},{"date":"2026-07-31","current":-25.605863,"twenty":-24.07378,"median":4.876179,"eighty":5.805676,"marketCap":3890409784},{"date":"2026-08-07","current":-25.770999,"twenty":-24.130978,"median":4.866283,"eighty":5.627239,"marketCap":3923102304},{"date":"2026-08-14","current":-27.150453,"twenty":-24.332526,"median":4.857543,"eighty":5.519282,"marketCap":4138328055},{"date":"2026-08-21","current":-27.786128,"twenty":-24.640614,"median":4.815493,"eighty":5.392136,"marketCap":4244578742}],"updateTime":1787489731801},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03378\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1153210622","title":"HANXBIO-B Buys Back 22,600 H Shares at Average HK$32.09; Treasury Stock Reaches 547,300 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1153210622","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153210622?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:43","pubTimestamp":1778499827,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HANXBIO-B) disclosed a share repurchase of 22,600 H shares on 11 May 2026 via on-market transactions on the Hong Kong Stock Exchange. The buyback was...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181469327","title":"HANXBIO-B (03378) Spends HK$725,000 on Share Buyback of 22,600 Shares on May 11","url":"https://stock-news.laohu8.com/highlight/detail?id=1181469327","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181469327?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:30","pubTimestamp":1778499017,"startTime":"0","endTime":"0","summary":"HANXBIO-B (03378) announced that on May 11, 2026, the company spent HK$725,000 to repurchase 22,600 shares.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1173","03378","BK1535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634283700","title":"Hanx Biopharmaceuticals files HKEX next-day return, discloses buyback at HKD 32.09/share","url":"https://stock-news.laohu8.com/highlight/detail?id=2634283700","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634283700?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:25","pubTimestamp":1778498715,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals repurchased 22,600 H shares on Exchange on May 11, 2026.Buyback priced at HKD 31.86 to HKD 32.3 per share; aggregate consideration HKD 725,272.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hanx Biopharmaceuticals  Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 11, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDLb6BxHC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1173","03378","BK1535","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147790994","title":"HANXBIO-B (03378) Allocates HK$704,500 for Share Buyback on May 8","url":"https://stock-news.laohu8.com/highlight/detail?id=1147790994","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147790994?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:40","pubTimestamp":1778240421,"startTime":"0","endTime":"0","summary":"HANXBIO-B (03378) announced that on May 8, 2026, the company repurchased 22,000 of its shares at a total cost of HK$704,500.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1173","BK1535","03378","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633453133","title":"Hanx Biopharmaceuticals files HKEX disclosure return, repurchases shares at HKD 32.02 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2633453133","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633453133?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:36","pubTimestamp":1778240215,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals repurchased 22,000 H shares on Exchange on May 8.Repurchase price range HKD 31.3 to HKD 32.42; aggregate price paid HKD 704,514.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hanx Biopharmaceuticals  Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDLlsVPn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1535","03378","BK1161","BK1173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158300541","title":"HANXBIO-B repurchases 16,600 H-shares for HK$0.52 million, treasury stock rises to 502,700 units","url":"https://stock-news.laohu8.com/highlight/detail?id=1158300541","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158300541?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:03","pubTimestamp":1778151809,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HANXBIO-B) disclosed a Next Day Return for 7 May 2026, detailing a small-scale share repurchase on the Hong Kong Stock Exchange. Key transaction details   •...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198590490","title":"HANXBIO-B (03378) Spends HK$795,700 on Share Buyback of 25,900 Shares on May 6","url":"https://stock-news.laohu8.com/highlight/detail?id=1198590490","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198590490?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:30","pubTimestamp":1778067011,"startTime":"0","endTime":"0","summary":"HANXBIO-B (03378) announced that on May 6, 2026, it repurchased 25,900 shares at a total cost of HK$795,700.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1173","BK1535","03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136940263","title":"Hanx Biopharmaceuticals buys back 32,700 H shares for HKD 0.97 million; treasury stock rises to 446,100 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1136940263","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136940263?lang=en_us&edition=fundamental","pubTime":"2026-04-29 21:03","pubTimestamp":1777467788,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. announced a next-day disclosure return dated 29 April 2026 detailing a further on-market share repurchase. The company bought back 32,700 H shares on 29...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159256179","title":"HANXBIO-B (03378) Spends HK$972,000 on Share Buyback of 32,700 Shares on April 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1159256179","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159256179?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:48","pubTimestamp":1777466891,"startTime":"0","endTime":"0","summary":"HANXBIO-B (03378) announced that on April 29, it repurchased 32,700 shares at a total cost of HK$972,000.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378","BK1161","BK1535","BK1173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631514816","title":"Hanx Biopharmaceuticals files HKEX disclosure, repurchases shares at HKD 29.74 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2631514816","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631514816?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:43","pubTimestamp":1777466586,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals filed next-day disclosure return reporting repurchase of 32,700 H shares on April 29, 2026.Buyback price range: HKD 29.06 to HKD 31 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hanx Biopharmaceuticals  Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL24JsRl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378","BK1535","BK1161","BK1173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121933131","title":"HANXBIO-B Repurchases Shares Worth HK$1.02 Million on April 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1121933131","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121933131?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:54","pubTimestamp":1777377250,"startTime":"0","endTime":"0","summary":"HANXBIO-B (03378) announced that on April 28, 2026, the company repurchased 34,900 shares at a cost of approximately HK$1.02 million. The repurchase price ranged between HK$28 and HK$30 per share.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1173","BK1535","03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101552983","title":"HANXBIO-B (03378) Allocates HK$1.06 Million for Share Buyback on April 27","url":"https://stock-news.laohu8.com/highlight/detail?id=1101552983","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101552983?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:22","pubTimestamp":1777292569,"startTime":"0","endTime":"0","summary":"HANXBIO-B (03378) announced that on April 27, 2026, the company executed a share repurchase, spending HK$1.06 million to buy back 38,000 shares. The repurchase price ranged from HK$26.50 to HK$28.58 per share.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1173","BK1535","03378","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630396042","title":"Hanx Biopharma files HKEX next-day return, discloses HKD 27.85 share buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2630396042","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630396042?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:13","pubTimestamp":1777292021,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals filed a next-day disclosure return reporting a repurchase of 38,000 H shares on April 27.Buyback price ranged from HKD 26.5 to HKD 28.58 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hanx Biopharmaceuticals  Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL5zZ0R3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1535","BK1161","BK1173","03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196859272","title":"HANXBIO-B（03378）2025年经营表现与结构升级：研发投入加码，资产大幅提升","url":"https://stock-news.laohu8.com/highlight/detail?id=1196859272","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196859272?lang=en_us&edition=fundamental","pubTime":"2026-04-27 17:50","pubTimestamp":1777283446,"startTime":"0","endTime":"0","summary":"2025年度，Hanx Biopharmaceuticals (Wuhan) Co.,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"HANXBIO-B（03378）2025年经营表现与结构升级：研发投入加码，资产大幅提升","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630736499","title":"Hanx Biopharmaceuticals releases 2025 ESG report","url":"https://stock-news.laohu8.com/highlight/detail?id=2630736499","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630736499?lang=en_us&edition=fundamental","pubTime":"2026-04-27 17:46","pubTimestamp":1777283188,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals reported FY 2025 Scope 2 greenhouse-gas emissions of 137.76 tonnes CO2e.Scope 3 emissions totaled 132.96 tonnes CO2e, taking combined Scope 2 and 3 emissions to 270.72 tonnes CO2e.Electricity consumption rose to 256,722 kWh from 221,255 kWh.Water consumption increased to 2,066 tonnes from 619 tonnes.Hazardous waste discharged climbed to 0.72 tonnes from 0.41 tonnes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hanx Biopharmaceuticals  Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL5KHwj7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1535","03378","BK1173","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630364911","title":"Hanx Biopharmaceuticals publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2630364911","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630364911?lang=en_us&edition=fundamental","pubTime":"2026-04-27 17:45","pubTimestamp":1777283109,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals released annual report for year ended Dec. 31, 2025, highlighting transition into capital markets following Hong Kong listing under stock code 3378.R&D focus stayed on immuno-oncology, ADCs, autoimmune diseases, with pipeline positioned as three clinical-stage candidates plus one IND-stage asset.Flagship HX009 advanced with positive interim efficacy signals in EBV-positive lymphoma, acral or mucosal melanoma.CTLA-4/SIRPα fusion protein HX044 expanded global development with parallel enrollment in China, Australia, targeting ICI-resistant solid tumors.First ADC candidate HX111, targeting OX40, secured NMPA IND clearance, with first-in-human trial planned in early 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advic","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDLb7kN6f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1535","BK1161","BK1173","03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182854264","title":"HANXBIO Executes HKD 1.06 Million Share Buyback, Lifts Treasury Stock to 0.25% of Mandated Limit","url":"https://stock-news.laohu8.com/highlight/detail?id=1182854264","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182854264?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:03","pubTimestamp":1777035807,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HANXBIO; H-share) disclosed a share repurchase on 24 April 2026, reducing its outstanding share count and increasing treasury stock as follows: •...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154342285","title":"HANXBIO-B (03378) Unveils Four Key Preclinical Research Findings at 2026 AACR Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1154342285","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154342285?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:02","pubTimestamp":1777035779,"startTime":"0","endTime":"0","summary":"HANXBIO-B (03378) announced that the company presented four core preclinical research results in poster sessions at the 2026 American Association for Cancer Research (AACR) Annual Meeting, held from...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1173","BK1535","BK1161","03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629841980","title":"Hanx Biopharmaceuticals says HX044 enters Phase I after positive preclinical data at AACR","url":"https://stock-news.laohu8.com/highlight/detail?id=2629841980","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629841980?lang=en_us&edition=fundamental","pubTime":"2026-04-24 20:49","pubTimestamp":1777034990,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals presented four oncology R&D posters at 2026 AACR annual meeting held April 17-22 in San Diego.Preclinical findings supported clinical development of HX044, a CTLA-4 x CD47 program now in Phase I, with modeling suggesting a wider therapeutic window versus ipilimumab.Separate preclinical posters on PD-L1-focused antibody-drug conjugates, including HX116 and HX112, indicated tumor-targeted activity in 3D tumor organoid testing with potential for improved specificity versus a leading clinical comparator.Hanx also highlighted a 3D tumor organoid evaluation platform positioned as more predictive of in vivo anti-tumor effects than conventional 2D cell assays, aiming to streamline ADC candidate selection.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL4bcfXd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378","BK1535","BK1173","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176038362","title":"HANXBIO-B spends HKD 0.99 million to repurchase 31,200 H shares; outstanding shares (ex-treasury) trimmed to 135.94 million","url":"https://stock-news.laohu8.com/highlight/detail?id=1176038362","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176038362?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:23","pubTimestamp":1776860601,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HANXBIO-B) disclosed that on 22 April 2026 it bought back 31,200 H shares on the Hong Kong Stock Exchange. The transaction was executed within a price range...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":6,"totalSize":147,"code":"91000000","status":"200"}]}}